MicroRNA-17-92 is required for the T-cell and B-cell pathogenicity that drives chronic graft-versus-host disease (cGVHD) after allogeneic bone marrow transplant (BMT), report investigators. Data from cGVHD mouse models showed that, by determining T-cell and B-cell differentiation and function, miR-17-92 is responsible for cGVHD development. Inhibiting miR-17 is a potential therapeutic strategy for preventing cGVHD in BMT patients.
from Top Health News -- ScienceDaily https://ift.tt/2IkRIxq
the news of the day, for today, top news of today, world news today live, top local news, top news stories of the day, top news today in the world, news today nyc, top news today local,
Subscribe to:
Post Comments (Atom)
A Wife's Skydiving Fall Looked Like a Tragic Accident. Then Police Discovered Something More Sinister
from Yahoo News - Latest News & Headlines https://ift.tt/WsVUQLh
-
from Yahoo News - Latest News & Headlines https://ift.tt/m2VMCS1
-
from Yahoo News - Latest News & Headlines https://ift.tt/EKoFvQy
-
from Yahoo News - Latest News & Headlines https://ift.tt/jYPuwNf
No comments:
Post a Comment